inoculum of Klebsiella pneumoniae. For daily fractionated doses of marbofloxacin, the 23 prevention of resistance occurred for an AUC/MIC ratio of 189h for the low inoculum 24 whereas for the high inoculum, resistant subpopulation enrichment occurred for AUC/MIC 25 values up to 756h. For the high inoculum infected rats, the AUC/MIC, C max /MIC and time 26 within the Mutant Selection Window (T MSW ) were not effective predictors of resistance 27 prevention when comparing fractionated and single administrations. An index corresponding 28 to the ratio of the time the drug concentrations were above the MPC and within the MSW 29 (T >MPC /T MSW ) was the best predictor of the emergence of resistance: a T >MPC /T MSW of 0.54 30 was associated with the prevention of resistance for both fractionated and single 31 administrations. These results suggest that the enrichment of resistant bacteria depends 32 heavily on the inoculum size at the start of an antimicrobial treatment, and that classical 33 PK/PD parameters cannot adequately describe the impact of different dosage regimens on 34 resistant bacteria enrichment. We propose an original index, the ratio T >MPC /T MSW , that 35 reflects the proportion of time the less susceptible bacterial subpopulation is killed over the 36 time it is selected, as a potentially powerful indicator of the prevention of resistant bacteria 37 enrichment. This ratio is valid only if plasma concentrations achieved the MPC. 38
INTRODUCTION 39
In infections such as pneumonia, the burden of microorganisms can become quite high 40 and may frequently exceed the inverse of the frequency of mutations, leading to the 41 development of a resistant subpopulation. This leads to the presence of a small subpopulation 42 of resistant organisms at the time that antimicrobial therapy is initiated. Under these 43 conditions, a drug exposure that will kill only the susceptible dominant population may allow 44 amplification of the resistant mutant subpopulation that is present before treatment, resulting 45 in the emergence of resistance during therapy (24, 38) . 46
Resistance to fluoroquinolones can occur spontaneously in bacterial populations at a 47 frequency of about 10 -6 to 10 -8 (6) following a stepwise process that involves mutations in the 48 genes coding for the targets, DNA gyrase and topoisomerase IV (21, 32) . Therefore, we can 49 presume that an increase in the bacterial load at the infection site could be associated with an 50 increase in the likelihood of a resistant mutant subpopulation being present before any 51 fluoroquinolone treatment is administered. 52
Until recently, optimization and individualisation of antimicrobial dosing regimens 53 have been primarily based on the pharmacokinetic/pharmacodynamic (PK/PD) indices that 54 describe both the optimal efficacy and/or prevention of toxicity (27) The marbofloxacin doses were administered according to the following time schedule: either 118 in one single administration or the same total dose was fractionated in 4 daily administrations 119 over 4 days. For group A, a single total marbofloxacin dose (16 mg/kg) was tested according 120 to the time schedule. For group B, three total marbofloxacin doses were tested: i.e. 16, 64 and 121 100 mg/kg according to the time schedule. Animals were sacrificed 96 hours after the first 122 marbofloxacin administration by an intraperitoneal injection of pentobarbital sodium 123 (Dolethal ND , Vetoquinol, France). The lungs were aseptically removed and homogenized in 124 10mL of NaCl 0.9%. The homogenates were centrifuged at 3000g for 10 minutes and washed 125 twice in 10mL of NaCl 0.9% to prevent drug carry-over. Ten microliters of successive 10-fold 126 dilutions of the homogenates were then plated in triplicate on MH drug-free agar plate 127 containing 10% activated charcoal and 10% MgSO 4 and 100µL of the homogenates were 128 plated on Mac Conkey agar supplemented with 0.064µg/mL and 0.256µg/mL marbofloxacin. 129
Colonies were counted after overnight incubation at 37°C. If the colonies were too small, 130 7/30 incubation was continued for a further 24 hours. The lowest level of detection was 131 100 CFU/lung and bacteria were considered eradicated below this level. Ten to twelve rats 132 were included per treatment group. The proportion of resistant bacteria was calculated as the 133 ratio of bacterial counts in the presence of 0.064 or 0.256 µg/mL marbofloxacin over the total 134 bacterial counts on plates without marbofloxacin. 135
Pharmacokinetics. 136
Two satellite groups (Group C and D) of male OFA rats (Charles River, L'arbresle, France), 137 weight 250-270g, were catheterized in the femoral vein. After three days, the rats' lungs were 138 inoculated with 0.05 mL of an inoculum of 2 × 10 6 CFU/mL (Group C) or 2 × 10 10 CFU/mL 139 (Group D) of KP. Four hours after the inoculation group C was given a single subcutaneous 140 dose of marbofloxacin. For the group D, marbofloxacin administration was 24 hours after the 141 KP inoculation. The doses were 4 and 16 mg/kg for group C, and 4 , 16 and 100 mg/kg for 142 group D. Blood samples (200µL) were collected at 0. 25, 0.5, 1, 2, 4, 6, 8, 12, 24 and 48 hours 143 after dosing. Two to four rats were included per treatment group. After each serial blood 144 sample, a volume of physiological saline equivalent to the collected blood volume was 145 administered. Blood samples were centrifuged at 7000 g for 10 min at 4 °C and plasma was 146 stored at -20 °C until assay. A high performance liquid chromatography method, with 147 fluorescence detection (λ exc = 295 nm, λ em = 500 nm) (Agilent 1100) was adapted from 148 Schneider et al. (30) to determine the marbofloxacin concentrations in the rat plasma. Briefly, where within the range of the calibration curve. The accuracy varied from 104.1 to 107.5% 157 and the intra-day and inter-day precision were lower than 6.2% and 8.2% respectively. The 158 limit of quantification was 20 ng/mL. 159
Pharmacokinetic analysis and PK/PD indices. 160
Pooled pharmacokinetic data were analysed using software dedicated to population 161 pharmacokinetic analysis (MONOLIX) (22), an approach that is consistent with properly 162 analysing sparse data as described by Burtin et al. (7) . Estimations were performed using 163 calculated using the area under the concentration-time curve at steady-state over 24h for the 172 fractionated administrations as defined by Mouton et al. (28) and using AUC 0-∞ for the single 173 administrations as proposed by Toutain et al. (33) . The T MSW and T >MPC were calculated in the 174 same way, over 24h for the fractionated administrations and over 96h for the single 175 administrations. As the plasma protein binding of marbofloxacin is lower than 10 % in the rat 176 (14), the PK/PD indices were determined from total plasma concentrations. 177
The sigmoid inhibitory Emax models describing the relationships between PK/PD indices and 178 the proportion of resistant bacteria for the high inoculum 96h after the start of marbofloxacin The MIC of marbofloxacin was 0.032µg/mL for Klebsiella pneumoniae (ATCC43816) and 184 the MPC was 0.512µg/mL. The term "R-2×MIC" in the present paper should be understood 185 as bacteria growing on 0.064 µg/ml marbofloxacin (2 × MIC), and the term "R-8×MIC" 186 should be understood as bacteria growing on 0.256 µg/mL marbofloxacin (8 × MIC). The total bacterial population 96 hours after the start of marbofloxacin treatment is reported 212 for each inoculum size and each marbofloxacin dosing regimen in Table 1 Table 1 . In rats infected with the low inoculum and treated with 16 mg/kg of 231 12/30 marbofloxacin, neither R-2×MIC nor R-8×MIC bacteria were detected at the end of the 232 experiment. By contrast, rats infected with the high inoculum had both R-2×MIC and R-233 8×MIC bacteria in their lungs. The frequency of rats harbouring these two KP subpopulations 234 was negatively associated with the marbofloxacin doses. Moreover, for the same total 235 marbofloxacin dose, fractionated administration seemed to be associated with a lower 236 presence of resistant subpopulations than the single dose administration. 237
Pharmacokinetic study. 238
The pooled pharmacokinetic data obtained with different marbofloxacin doses were 239 successfully analysed using the same compartmental model, indicating dose-proportionality 240 of marbofloxacin kinetics within both the low and high inoculum groups. This proportionality 241 enabled PK/PD indices to be calculated for the different marbofloxacin doses. Moreover, no 242 significant difference in marbofloxacin pharmacokinetic parameters was observed between 243 the low and high inoculum groups receiving the same doses (data not shown). The predicted 244 concentrations versus time profiles of marbofloxacin for the different dosage regimens are 245 given in Figure 1 . 246 PK/PD indices and R-2× × × ×MIC and R-8× × × ×MIC subpopulation enrichment. 247
The PK/PD indices for the different marbofloxacin dosage regimens are shown in Table 2 . 248
The proportions of resistant KP subpopulations after the different dosage regimens in rats 249 infected with the high inoculum are shown in Figure 2 . In all animals carrying resistant 250 bacteria, the proportion of both R-2×MIC and R-8×MIC bacteria was higher than 10 -6 , 251
indicating an enrichment compared with the initial inoculated KP population (proportion < 10 with the high inoculum whereas there was no enrichment for animals infected with the low 257 inoculum (Table 1) . In animals infected with the high inoculum, AUC/MIC values of 4×756 258 and 1×3026 hours, for the fractionated and single 64 mg/kg administration respectively, were 259 also associated with R-2×MIC and R-8×MIC subpopulations whereas the ratios of 4×1182 260 and 1×4728 hours corresponding to the 100 mg/kg total dose were associated with the 261 absence of detection of R-8×MIC subpopulation (Table 1 and 2). 262
(ii) C max /MIC. In animals infected with the low inoculum (Group A), the C max /MIC value of 263 4×54 and 1×217 for fractionated and single 16 mg/kg administration respectively, were 264 associated with the absence of R-2×MIC or R-8×MIC subpopulation enrichment (Table 1 and  265 2). In animals infected with the high inoculum (Group B), the higher the C max /MIC value, the 266 less the R-2×MIC and R-8×MIC subpopulation enrichment occurred for each dosing regimen 267 (Table 1 and 2). The C max /MIC values that were associated with the absence of R-8×MIC 268 bacteria enrichment were 4×339 and 1×1357, for the fractionated and single 100 mg/kg 269 administrations respectively. The 4×339 ratio value for the fractionated administration was 270 also associated with the lower frequency of R-2×MIC subpopulation enrichment (Table 1 and (Table  275 2) and for the fractionated administration, T MSW was 50, 67 and 60 % of the time (over 276 24 hours) ( Table 2 ). The T MSW was lower for the 100 mg/kg dose compared to 64 mg/kg dose 277 as it was calculated over 24h and that the T >MPC was higher for the 100 mg/kg dose than for 278 the 64 mg/kg (i.e. 40% vs. 33% respectively) ( Table 2) (Fig. 2, panel A1 and A2 ). For T >MPC, there was a relationship 283 between T >MPC and the R-2×MIC or R-8×MIC subpopulation enrichment, only when each 284 dosage regimen was considered separately (fractionated or single) (Fig. 2, panel B1 and B2) . 285
In fact, there was a relationship between R-2×MIC or R-8×MIC subpopulation enrichment 286 and the ratio of T >MPC /T MSW (Fig. 2, panels C1 and C2) . Irrespective of the dosage regimen, 287 the closer the T >MPC /T MSW ratio came up to 1, the more the R-2×MIC or R-8×MIC 288 subpopulation enrichment was limited. initial small bacterial population at the infection site (Group A), we never observed a R-318 2×MIC or R-8×MIC subpopulation enrichment. In addition, the total bacterial load decreased 319 dramatically. On the contrary, with a delayed start of the antimicrobial treatment on an initial 320 16/30 large bacterial population (Group B), we observed a limited decrease in the total bacterial 321 population, accompanied by an enrichment of R-2×MIC and R-8×MIC subpopulations, 322 depending on the marbofloxacin dosing regimen. Moreover, for the smaller marbofloxacin 323 dose (16 mg/kg) administered as a single administration, 4 out of 10 rats died between 72 and 324 96h after the start of marbofloxacin treatment. These deaths were attributed to the infection, 325 based upon observed clinical signs of infection in these rats. On the contrary, the 3 deaths 326 observed with the highest single marbofloxacin dose (100 mg/kg) were unlikely to have been 327 due to infection because they occurred in the first 48h after the inoculation while in non-328 treated animals death always occurred after 72h . These early deaths could be attributed to the 329 marbofloxacin toxicity in ill animals. 330
The ability of PK/PD indices such as AUC/MIC, C max /MIC, T >MPC and T MSW to 331 predict resistant subpopulation enrichment has already been studied. Previous studies 332 suggested that AUC/MIC was the PK/PD index that best correlated with efficacy of 333 fluoroquinolones in both neutropenic and non-neutropenic murine thigh and lung infection 334 models (3, 5, 13, 34). In our study, for the low inoculum (Group A) with the lowest 335 marbofloxacin dose (16 mg/kg), the AUC/MIC value of 4×189 hours or 1×756 hours for 336 fractionated or single dose administration respectively, was associated with the prevention of 337 the emergence of any resistant subpopulation after 96 hours of treatment. For the high 338 inoculum (Group B), the AUC/MIC values required to prevent R-8×MIC subpopulation 339 enrichment were higher than for the low inoculum, i.e. 4×1,182 hours and 1×4,728 hours for 340 fractionated and single administration respectively. However, considering the MPC, which is 341 linked to the MIC of the R-8×MIC bacteria, to calculate the corresponding PK/PD indices, it 342 appears that the AUC/MPC ratio which was associated with the prevention of the enrichment 343 of an R-8×MIC subpopulation is now 4×74 hours or 1×295 hours for fractionated or single 344 administration respectively. These AUC/MPC values are of the same order of magnitude as 345 17/30 the AUC/MIC values obtained to prevent an R-8×MIC subpopulation enrichment from a low 346 initial inoculum. In other words and as previously suggested (38), to be predictive, the 347 AUC/MIC ratio should take into account the MIC of the subpopulation having the highest 348 MIC value and not the MIC of the dominant population. Moreover, the differences observed 349 between R-8×MIC enrichment for fractionated and single dose administrations indicated that, 350 for a same total exposure (over 96h), the effectiveness of the fractionated dosage regimen is 351 greater than that of a single dose administration; this suggest that enrichment of resistant 352 subpopulations is co-dependent on both the total exposure and the time above some critical 353
concentration (see later). 354
The time the fluoroquinolone concentrations were within the Mutant Selection 355
Window has previously been shown to be associated with a promotion of resistant bacteria 356 subpopulation enrichment in vitro (1, 9, 10, 15) and in vivo (16). However, we did not 357 observe in our experiment such a relationship between T MSW and R-8×MIC subpopulation 358 enrichment (Fig. 2 , panels A1 and A2), which is in agreement with a previous in vitro study 359 with Staphylococcus aureus (8) although it is important to note that the target of mutation 360 resistance differs between gram positive and gram negative bacteria (11). Recently, it was 361 suggested that the apparent inability of T MSW to predict mutant resistant enrichment may be 362 explained by the confounding influence of the actual antimicrobial concentrations at the edges 363 of the selection window (10, 17). In other words, for a given T MSW , situations are not 364 equivalent when time outside the MSW is under the MIC or above the MPC. In the present 365 study, for the fractionated 16 mg/kg dose, the half-life of marbofloxacin of 2.41h (Fig. 1) led 366 plasma concentrations to decay below the MSW whereas for the 2 other doses (64 and 367 100 mg/kg), most of the exposure to marbofloxacin was at the top of the MSW. This could 368 explain the absence of a relationship between T MSW and R-8×MIC enrichment. For the single 369 dose administration, the pharmacokinetic profiles showed that for the two highest doses (64 370 18/30 and 100 mg/kg), marbofloxacin concentrations reside almost the same time within the MSW 371 while the residence time within the MSW was shorter for the lower dose (16mg/kg). There 372 was thus no relationship between the T MSW and R-8×MIC subpopulation enrichment. By 373 contrast, there was a relationship between both R-2×MIC and R-8×MIC subpopulation 374 enrichment and the ratio T >MPC /T MSW (Fig. 2, panels C1 and C2, Fig. 3, panels B1 and B2) . 375
With this ratio, it is now possible to discriminate between situations characterized by the same 376 T MSW but with different levels of antimicrobial concentrations within this MSW, and the 377 higher is this ratio, the lower the risk of R-8×MIC subpopulation enrichment. The ability of 378 this new index to predict enrichment of resistant mutants is due to the fact that it consists of 379 two terms reflecting two antagonistic and sequential processes: T >MPC , that reflects the time 380 during which the antibiotic eliminates all pathogens including resistant mutants, and T MSW , 381 that reflects the time during which the antibiotic produces selection of mutant resistant 382 subpopulations. It is noteworthy that this ratio allows an unbiased comparison of fractionated 383 and single dose administrations given that for fractionated administration, the ratio is the same 384 when calculated over 24h or the total duration of the treatment (96h). Cut-off values of 385 T >MPC /T MSW associated with the prevention of resistant subpopulation enrichment need to be 386 known; as shown in the present experiment, the ratio is influenced by the likelihood of having 387 resistant mutants already present at the start of antimicrobial treatment. With the low 388 inoculum (Group A), T >MPC /T MSW values of 0.31 and 0.30, for fractionated and single dose 389 administration respectively, were required to prevent mutant resistant enrichment. By contrast 390 for the high inoculum (Group B) the corresponding values were 0.67 and 0.54 respectively. 391
From our results, it appears that the most desirable situation to carry out an antimicrobial 392 therapy that does not simultaneously promote antimicrobial resistance is one in which the 393 inoculum size at the initiation of the treatment is low or null (metaphylaxis, prophylaxis). In a 394 curative setting, characterized by a greater likelihood of the antimicrobial facing a high 395 19/30 bacterial load, our results suggest that the best strategy would be to immediately achieve 396 plasma concentrations above the MPC. Besides such intuitive findings, the present study 397 offers the first evidence of the rational PK/PD approach to select the antimicrobial dosage 398 regimens adapted to either preventive or curative settings. In addition, as shown by our 399 results, the T >MPC needs to be long enough to produce an early reduction of the inoculum load 400 to be in the same situation as with an initial low inoculum load. In the present experiment, it 401 appears that with the single marbofloxacin dose (mimicking the so called "one shot" 402 treatment that is usually recommended in veterinary medicine), T >MPC is not long enough to 403 achieve this goal. However, it is important to note that in our study, the tested doses always 404 achieved concentrations above the MPC for fractionated administration but the same total 405 fluoroquinolone dose which achieves a concentration above the MPC for a single but not for a 406 fractionated administration would have been be better in a single than in a fractionated 407 administration for mutant prevention. Secondly, the terminal half life of marbofloxacin in 408 domestic animal species may be much longer (up to 13 hours) than in rats (2.41 hours in our 409 study) and a single dose administration in large animal species may give a longer T >MPC than 410 in rats. 411
In addition to R-8×MIC subpopulation enrichment, we also studied the R-2×MIC 412 enrichment which could be attributed to efflux pump over-expression in bacteria (25). In 413 some animals we observed an enrichment of the R-2×MIC subpopulation without 414 simultaneous R-8×MIC subpopulation enrichment. For the two highest marbofloxacin doses 415 (64 and 100 mg/kg), the R-2×MIC subpopulation enrichment was greater for the single 416 administration than the fractionated one (Table 1) . This could in turn explain the higher 417 percentage of animals harbouring R-8×MIC bacteria in their lungs with a single rather than a 418 fractionated administration of marbofloxacin at 64 mg/kg. Indeed, if the R-2×MIC 419 subpopulation enrichment is promoted, the ability of these bacteria to survive antimicrobial 420 20/30 concentrations closer to the MIC favours the possibility of generating a new and more 421 resistant subpopulation (R-8×MIC bacteria), as has been suggested by Louie et al. (25) . Thus 422 despite the same impact on the total bacterial population, in our model the single 423 antimicrobial administration seems to be less beneficial than the fractionated administration in 424 preventing resistant mutant enrichment. 425
In conclusion lungs. 566 ** The death of these 3 rats occurred during the 24 first hours after the drug administration. 567
The 3 animals that died 24h hour after marbofloxacin administration were considered as 568 dying because of toxicity of the high dose of marbofloxacin administered in single-injection 569 and are not included in the percentages. 570 nd: not determined 571
Dead rats are not taken into consideration to calculate the total bacterial population in lungs. 572 
